Key result
Acquiring the Affinit 30 CDU device for cardiac surgery yields a ~273% internal rate of return.
Why the study?
Cerebrovascular accidents complicate 10% of cardiac surgeries, and preventing complications with Color Doppler ultrasound could reduce unplanned postoperative treatment costs.
Does the acquisition and use of the 'Affinit 30' CDU device prove economically profitable and medically justified in cardiac surgery patients?
Does the acquisition and use of the 'Affinit 30' CDU device prove economically profitable and medically justified in cardiac surgery patients?
The acquisition of the 'Affinit 30' CDU device for cardiac surgery patients is highly economically profitable, with an NPV of 948,850 KM and an IRR of 273%.
Answers are grounded in this paper and cite their sources.
Economic analysis supports device consideration in cardiac surgery; leaves open need for outcome trials before adoption.
Background: Cerebrovascular accidents (CVI) are considered the second most serious complication in cardiac surgery patients with a frequency of 10%. By preventing complications of surgical treatment, using a Color Doppler ultrasound (CDU) device, in the population of cardiac surgery patients, the unplanned costs of prolonged postoperative treatment would be reduced. Objective: To prove that the acquisition and use of the newly developed CDU device "Affinit 30" is completely economical, profitable and medically justified. Methods: Numerical parameters of the treatment of cardiovascular patients were analyzed (number of procedures, number of days in the intensive care unit, cost of additional consultative services of the clinic for radiology and neurology), and the calculated economic value of the potential investment, as well as the cost of preventing surgical complications, by purchasing and installing a new modern CDU device. Results: The profitability of the investment was assessed using the economic parameters Net Present Value (NPV) of the investment, Internal rate of return (IRR) and Profitability Index (PI). A mathematical calculation with the given parameters yields NPV = 948,850 KM and IRR of 273% when applied to the given parameters. The PI value is 12.6, which matches the previously calculated NPV and IRR values. Conclusion: The acquisition and use of the newly developed CDU device "Affinit 30" is economically profitable and medically justified. This is shown by the calculated values of the economic parameters Net Present Value of the investment (NPV), Internal rate of return (IRR) and the Profitability Index (PI).
No takes yet. Share an insight, caveat, or question.
Karić et al. (2023) studied Cardiac surgery patients. Color Doppler ultrasound (CDU) device 'Affinit 30' was evaluated on Profitability of the investment (Net Present Value, Internal rate of return, Profitability Index). Acquisition of the CDU device 'Affinit 30' for cardiac surgery patients is economically profitable, yielding a Net Present Value of 948,850 KM and an Internal Rate of Return of 273%.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: